Form D · Biotechnology
PuraCath Medical, Inc.
San Francisco, CA · CIK 0001641959
Offering snapshot reported Jun 23, 2020 · SEC filing
- Reported sold
- $346K Offering amount: $346K
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $199 Reported outside-investor minimum
- First sale
- Jun 2, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 23, 2020 | Initial | $346,002 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 04
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $26K
- Finders' fees
- $0
- Form D file number
- 021-369464
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| SI Securities, LLC | 170937 |
Source: Form D, filed Jun 23, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Julia Rasooly | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
660 4 Th Street, #104
San Francisco, CA, 94107
San Francisco, CA, 94107